<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8"/>
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Science & Pipeline — Prolium Bio</title>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;700;900&display=swap" rel="stylesheet">
  <style>
    :root{
      --prolium-blue:#63c5ed;
      --prolium-green:#21c036;
      --text-main:#123e47;
      --prolium-orange:#FF991C;
      --prolium-dark:#0e2f36;
      --bg-green-0:#e9f8f0;
      --bg-green-1:#dbf6e6;
      --bg-green-2:#b6efce;
      --bg-green-3:#6ce49a;
      --bg-green-4:#21c036;

      --wave-width: 1920px;
      --wave-height: 540px;

      --step--1: clamp(0.9rem, 0.7rem + 0.6vw, 1.05rem);
      --step-0:  clamp(1rem, 0.85rem + 0.8vw, 1.25rem);
      --step-1:  clamp(1.15rem, 0.95rem + 1.1vw, 1.5rem);
      --step-2:  clamp(1.75rem, 1.2rem + 2.4vw, 2.5rem);
      --step-3:  clamp(2.5rem, 1.6rem + 4.8vw, 3.6rem);
    }

    html{ font-size:16px; overflow-x:hidden; scroll-padding-top:80px; }
    body{
      margin:0;min-height:100%;
      color:var(--text-main);
      font-family:'Inter',Arial,sans-serif;
      font-size: var(--step-0);
      line-height:1.6;
      background:linear-gradient(180deg,
        var(--bg-green-4) 0%,
        var(--bg-green-4) 45%,
        var(--bg-green-3) 70%,
        var(--bg-green-2) 100%);
      background-attachment:local;
      overflow-x:hidden;
      scroll-behavior:smooth;
      padding-top:80px; /* offset for fixed nav */
    }

    /* NAV — now fixed */
    .nav{
      display:flex;justify-content:space-between;align-items:center;
      padding:10px 20px;background:rgba(255,255,255,0.47);backdrop-filter:blur(6px);
      position:fixed; top:0; left:0; right:0; z-index:10000; gap:14px;
      transition: box-shadow .2s ease, background-color .2s ease;
    }
    .nav.scrolled{ box-shadow:0 6px 18px rgba(0,0,0,.12); background:rgba(255,255,255,0.86); }
    .nav-brand{display:flex;align-items:center;gap:14px}
    .nav-logo{height:clamp(44px, 34px + 2.5vw, 72px);width:auto}
    .nav-links{display:flex;align-items:center;gap:clamp(0.5rem, 0.3rem + 1vw, 1.1rem)}
    .nav-links a{
      font-size:var(--step--1);
      font-weight:800;letter-spacing:.005em;line-height:1;
      color:#0b2f39;text-decoration:none;
      padding:clamp(6px, 4px + .6vw, 10px) clamp(8px, 6px + .7vw, 12px);
      background:none;border:none;cursor:pointer;border-radius:9999px;
      transition:background .16s,color .16s;
    }
    .nav-links a:hover, .nav-links a.active{background:var(--prolium-green);color:#fff}

    .nav-toggle{
      display:none;background:none;border:none;
      font-size:clamp(1.6rem, 1.2rem + 2.2vw, 2rem);
      cursor:pointer;border-radius:9999px;
    }
    .drawer{
      position:fixed;top:0;right:-100%;height:100%;
      width:min(55vw,260px);
      background:rgba(255,255,255,0.47);
      backdrop-filter:blur(6px);
      transition:right .28s ease;
      z-index:20000;padding:20px;
      display:flex;flex-direction:column;gap:.5rem;
      box-shadow:-4px 0 10px rgba(0,0,0,0.08);
    }
    .drawer.open{right:0}
    .drawer a{
      color:#0b2f39;text-decoration:none;font-weight:800;
      text-align:left;font-size:var(--step--1);padding:10px 8px;border-radius:12px
    }
    .drawer a:hover{background:#f3f7fb}
    @media(max-width:900px){.nav-links{display:none}.nav-toggle{display:block}}

    .hero{
      position:relative;isolation:isolate;
      min-height:120svh;
      display:flex;align-items:center;justify-content:center;
      text-align:center;background:#fff;
      margin-top:-30svh;margin-bottom:-5svh;
      overflow:hidden;
    }
    .hero-content{position:relative;z-index:4;max-width:min(1100px,92vw);transform:translateY(-56px);}
    .hero-title{
      font-size: clamp(2.8rem, 2rem + 5vw, 4.2rem);
      line-height:1.2;font-weight:900;letter-spacing:-0.02em;
      margin:0 0 14px;color:#0e2f36;text-shadow:0 1px 0 rgba(255,255,255,.25);
    }

    .wave-wrap{
      position:absolute;left:50%;bottom:0;
      width:var(--wave-width);height:var(--wave-height);
      transform:translateX(-50%);
      z-index:1;pointer-events:none;overflow:hidden;
    }
    .wave{position:absolute;left:0;bottom:0;width:var(--wave-width);height:var(--wave-height);}
    .wave svg{display:block;width:var(--wave-width);height:var(--wave-height);}
    @keyframes waveBreathBack{0%,100%{transform:scaleY(1)}50%{transform:scaleY(1.03)}}
    @keyframes waveBreathFront{0%,100%{transform:scaleY(1)}50%{transform:scaleY(1.06)}}
    .wave--back svg{animation:waveBreathBack 12s ease-in-out infinite}
    .wave--front svg{animation:waveBreathFront 16s ease-in-out infinite; transform-origin:50% 100%;}
    .hero::after{content:"";position:absolute;left:0;right:0;bottom:-2px;height:4px;background:#21c036;z-index:2;}

    .wrap{max-width:1120px;margin:0 auto;padding:0 5vw}

    .page-nav{display:flex;justify-content:center;gap:10px;flex-wrap:wrap;margin:-24px auto 10px;position:relative;z-index:3}
    .page-chip{font-weight:700;color:#0a3f14;background:rgba(255,255,255,.7);padding:8px 14px;font-size:calc(var(--step--1)*0.95);text-transform:uppercase;letter-spacing:.06em;text-decoration:none;border-radius:9999px;margin-top: 5%;}

    .section-title{
      font-size:var(--step-2);
      margin:0 auto clamp(8px, 1vh, 18px);
      color:var(--prolium-dark);font-weight:900;letter-spacing:-0.01em;
      text-align:center;width:fit-content;
    }
    .section-desc,.lead-blurb{font-size:var(--step-1);color:var(--prolium-dark);font-weight:700;max-width:min(980px,90vw);margin:0 auto;line-height:1.55;text-align: left;}

    .lead-section{margin:clamp(54px,8vh,96px) auto 0;text-align:center}
    .lead-title{font-size:var(--step-2);color:#0b2f39;font-weight:800;margin:0 0 12px;letter-spacing:-0.01em;text-shadow:0 1px 0 rgba(255,255,255,.28)}
    .lead-note{display:inline-block;margin:0 auto 12px;font-weight:800;color:#0a3f14;background:rgba(255,255,255,.6);padding:7px 12px;font-size:calc(var(--step--1)*0.85);text-transform:uppercase;letter-spacing:.08em;border-radius:9999px}

    .how{margin:clamp(64px,8vh,96px) auto 0;text-align:center}
    .how-title{font-size:var(--step-2);color:#0b2f39;font-weight:800;margin:0 0 16px;text-shadow:0 1px 0 rgba(255,255,255,.25)}
    .steps{display:flex;justify-content:center;gap:28px;flex-wrap:wrap;position:relative}
    .step{flex:1 1 240px;max-width:300px;min-width:220px;text-align:center}
    .ico{width:78px;height:78px;border-radius:50%;background:radial-gradient(closest-side,#ffffff 0%,#ffffffcc 60%,#ffffff00 100%);display:grid;place-items:center;margin:0 auto 10px;box-shadow:0 8px 26px rgba(0,0,0,.12)}
    .ico svg{width:40px;height:40px}
    .step h3{font-size:calc(var(--step--1)*1.05);font-weight:800;color:#0a3f14;margin:8px 0 6px;letter-spacing:.01em}
    .step p{font-size:var(--step--1);font-weight:600;color:#0f3b3f;margin:0}
    .steps::before{content:"";position:absolute;top:39px;left:6%;right:6%;height:3px;background:linear-gradient(90deg, rgba(255,255,255,.0), rgba(255,255,255,.7), rgba(255,255,255,.0));border-radius:3px;pointer-events:none}
    @media (max-width:760px){ .steps::before{display:none} }

    .why{margin:clamp(64px,8vh,96px) auto 0}
    .why-title{font-size:var(--step-2);color:#0b2f39;font-weight:800;margin:0 0 14px;text-align:center;text-shadow:0 1px 0 rgba(255,255,255,.25)}
    .why-list{display:grid;grid-template-columns:repeat(3,1fr);gap:14px}
    .why-item{display:flex;gap:10px;align-items:flex-start}
    .tick{flex:0 0 28px;height:28px;display:grid;place-items:center;background:rgba(255,255,255,.75);box-shadow:0 4px 16px rgba(0,0,0,.12);border-radius:9999px}
    .tick svg{width:16px;height:16px}
    .why-item p{margin:0;font-weight:700;color:#0e3a27;line-height:1.6}
    @media (max-width:940px){ .why-list{grid-template-columns:1fr 1fr} }
    @media (max-width:600px){ .why-list{grid-template-columns:1fr} }

    .pipeline{margin:clamp(80px,9vh,110px) auto 0;text-align:center}
    .pipeline .section-kicker{display:inline-block;margin:0 auto 12px;font-weight:800;color:#0a3f14;background:rgba(255,255,255,.6);padding:7px 12px;font-size:calc(var(--step--1)*0.82);text-transform:uppercase;letter-spacing:.08em;border-radius:9999px}
    .pipeline .checks{max-width:980px;margin:0 auto;display:grid;grid-template-columns:1fr 1fr;gap:12px;text-align:left}
    .pipeline .check{display:flex;gap:10px;align-items:flex-start}
    .pipeline .tick{flex:0 0 28px;height:28px;display:grid;place-items:center;background:rgba(255,255,255,.75);box-shadow:0 4px 16px rgba(0,0,0,.12);border-radius:9999px}
    .pipeline .tick svg{width:16px;height:16px}
    .pipeline .check p{margin:0;font-weight:700;color:#0e3a27;line-height:1.6}
    @media (max-width:800px){ .pipeline .checks{grid-template-columns:1fr} }

    .cta{text-align:center;margin:72px 0 36px}
    .cta-link{
      color:#fff;background:linear-gradient(90deg,#1aa62f,#128d27);
      font-weight:800;padding:14px 30px;font-size:var(--step--1);
      text-decoration:none;display:inline-block;border-radius:9999px;
    }

    .nav-links a:focus-visible,
    .drawer a:focus-visible,
    .cta-link:focus-visible,
    .nav-toggle:focus-visible,
    .page-chip:focus-visible{
      outline: 3px solid rgba(99,197,237,.65);
      outline-offset: 2px;
    }

    @media (max-width:560px){
      .hero{min-height:100svh}
      .nav-logo{height:60px}
    }
    @media (prefers-reduced-motion:reduce){
      *{animation:none!important;transition:none!important}
    }
    img{max-width:100%;height:auto;align-self: center;}

    /* --- TCE section styling (mirrors requested layout) --- */
    .tce{margin:clamp(64px,8vh,96px) auto 0}
    .tce-header{max-width:min(980px,90vw);margin:0 auto 14px;text-align:left}
    .tce-title{
      font-size:var(--step-2);
      font-weight:900;
      letter-spacing:-0.01em;
      color:var(--prolium-dark);
      margin:0 0 10px;
      text-align:left;
    }
    .tce-intro, .tce-body{font-size:var(--step-1);color:var(--prolium-dark);font-weight:700;line-height:1.6;margin:0 auto 12px;max-width:min(980px,90vw)}
    .tce-list-wrap{max-width:min(980px,90vw);margin:8px auto 12px}
    .tce-list{
      margin:0 0 0 1.1rem;
      padding:0;
      display:block;
      list-style:disc;
      font-size:var(--step-1);
      color:var(--prolium-dark);
      font-weight:700;
      line-height:1.6;
    }
    .tce-list li{margin:6px 0}
    .tce-hr{
      border:0;height:1px;
      background:linear-gradient(90deg,rgba(255,255,255,0),rgba(0,0,0,.12),rgba(255,255,255,0));
      margin:18px auto;max-width:min(980px,90vw)
    }
  </style>
</head>
<body>
  <!-- NAV -->
  <nav class="nav" role="navigation" aria-label="Primary">
    <div class="nav-brand">
      <a href="index.html" style="display:flex;align-items:center;gap:14px;text-decoration:none">
        <img class="nav-logo" src="Prolium_color_transparent (1) (1).png" alt="Prolium Logo">
      </a>
    </div>
    <div class="nav-links" aria-label="Primary links">
      <a href="index.html">Home</a>
      <a href="science.html" class="active">Science & Pipeline</a>
      <a href="trials.html">Clinical Trials</a>
      <a href="about.html#about">About</a>
      <a href="contact.html">Contact</a>
    </div>
    <button class="nav-toggle" aria-label="Menu" aria-expanded="false">☰</button>
  </nav>

  <!-- Drawer -->
  <div class="drawer" id="drawer" role="dialog" aria-modal="true" aria-label="Mobile menu">
    <a href="index.html">Home</a>
    <a href="science.html" class="active">Science & Pipeline</a>
    <a href="trials.html">Clinical Trials</a>
    <a href="about.html#about">About</a>
    <a href="contact.html">Contact</a>
  </div>

  <!-- HERO -->
  <header class="hero" aria-label="Science overview">
    <div class="hero-content">
      <h1 class="hero-title">Science and Pipeline</h1>
      <nav class="page-nav" aria-label="On this page">
        <a class="page-chip" href="#pipeline">Pipeline</a>
        <a class="page-chip" href="#phase12">Phase I/II Results</a>
        <a class="page-chip" href="#TCE">TCE Overview</a>
      </nav>
    </div>

    <div class="wave-wrap" aria-hidden="true">
      <div class="wave wave--back">
        <svg preserveAspectRatio="none" viewBox="0 0 1440 540">
          <defs>
            <linearGradient id="bgBlue" x1="0" y1="0" x2="1" y2="0">
              <stop offset="0" stop-color="#63c5ed"/>
              <stop offset="1" stop-color="#9ed4ef"/>
            </linearGradient>
          </defs>
          <path d="M0,200 C180,160 320,110 540,180 C760,250 870,245 1040,160 C1210,80 1350,60 1440,100 L1440,540 L0,540 Z" fill="url(#bgBlue)"/>
        </svg>
      </div>
      <div class="wave wave--front">
        <svg preserveAspectRatio="none" viewBox="0 0 1440 540">
          <path d="M0,360 C260,480 420,410 680,370 C940,330 1110,360 1300,440 C1370,470 1410,500 1440,520 L1440,540 L0,540 Z" fill="#21c036"/>
        </svg>
      </div>
    </div>
  </header>

  <!-- CONTENT -->
  <main class="wrap">
    <!-- PIPELINE -->

    <section class="pipeline" id="pipeline" aria-label="Pipeline">
      <h2 class="section-title">Pipeline</h2>
      <p class="lead-blurb">
        Prolium’s first asset is PRO-203, a CD20xCD3 bispecific antibody. It works by binding
        both CD20, a protein that is broadly expressed on the surface of B-cells, and CD3,
        which is part of the T-cell receptor complex on T cells and is crucial for T-cell activation.
        Physically linking T-cells to B-cells causes T-cells to release cytotoxic molecules to kill
        the B-cell, even though the T-cell might not otherwise ordinarily recognize the B-cell as
        a target. <br><br>
        Originally developed by InnoCare and Keymed, PRO-203 was first studied in relapsed /
        refractory Non-Hodgkin’s lymphoma (NHL). Prolium plans to develop PRO-203,
        administered subcutaneously, for severe autoimmune diseases that are driven
        predominantly by aberrant B-cells.<br><br>
        Prolium is actively evaluating additional therapies that have the potential to treat severe
        autoimmune disease.
      </p>

      <section class="pipeline-visual" style="margin-top:10%; text-align:center">
        <div class="section-kicker">Placeholder not to be published in initial site launch: To be added once trials are announced</div>
        <figure style="margin:0 auto; display:inline-block">
          <img src="pipeline_vis.png" alt="Pipeline visualization" style="display:block;max-width:100%;height:auto;border-radius:16px;box-shadow:0 12px 28px rgba(0,0,0,.14)">
        </figure>
      </section>

      <div class="evidence" id="phase12" aria-label="Phase I/II (China) snapshot" style="margin-top:10%">
        <h3 class="section-title" style="margin-top:24px">Phase I/II snapshot (ICP-B02, China)</h3>
        <div class="checks">
          <div class="check">
            <div class="tick" aria-hidden="true">
              <svg viewBox="0 0 20 20" fill="none"><path d="M5 10l3 3 7-7" stroke="#168a2b" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/></svg>
            </div>
            <p>Phase I/II clinical trial in Relapsed and Refractory Non-Hodgkin’s lymphoma(NHL); conducted by InnoCare and Keymed (ICP-B02/CM355)</p>
          </div>
          <div class="check">
            <div class="tick" aria-hidden="true">
              <svg viewBox="0 0 20 20" fill="none"><path d="M5 10l3 3 7-7" stroke="#168a2b" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/></svg>
            </div>
            <p>Promising early results, particularly in follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL)</p>
          </div>
          <div class="check">
            <div class="tick" aria-hidden="true">
              <svg viewBox="0 0 20 20" fill="none"><path d="M5 10l3 3 7-7" stroke="#168a2b" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/></svg>
            </div>
            <p>Assessed safety, tolerability, PK, and preliminary anti-tumor activity</p>
          </div>
          <div class="check">
            <div class="tick" aria-hidden="true">
              <svg viewBox="0 0 20 20" fill="none"><path d="M5 10l3 3 7-7" stroke="#168a2b" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/></svg>
            </div>
            <p>Evaluated both IV and SC formulations</p>
          </div>
        </div>
      </div>
    </section>

    <!-- T-Cell Engagers (reformatted per request) -->
    <section class="tce" id="TCE" aria-label="T-Cell Engagers">
      <header class="tce-header">
        <h2 class="tce-title">The Potential of T-Cell Engagers as a Therapeutic Approach</h2>
      </header>

      <p class="tce-intro">
        T-cell engagers (TCEs) are engineered, bispecific antibodies that redirect T-cells to eliminate cells expressing a specific antigen. While initially pioneered in oncology to destroy tumor cells, TCEs are now being explored for autoimmune diseases, where the goal is to selectively deplete pathogenic immune cells.
      </p>

      <p class="tce-body">
        TCEs are typically bispecific antibodies or antibody fragments designed with:
      </p>

      <div class="tce-list-wrap">
        <ul class="tce-list">
          <li><strong>One arm binding CD3</strong>: a component of the T-cell receptor (TCR) complex on all T-cells.</li>
          <li><strong>One arm binding a disease-relevant target antigen</strong>, such as CD20 or CD19, expressed on B-cells.</li>
        </ul>
      </div>

      <p class="tce-body">
        When both arms engage their targets simultaneously, the TCE forms an immune synapse between the T-cell and the target cell, triggering T-cell activation, release of cytotoxic granules, and targeted killing of the bound cell — independent of MHC or traditional antigen recognition.
      </p>

      <p class="tce-body">
        T-cell engagers offer a transformative approach for autoimmunity by enabling precision depletion of disease-driving cells. By targeting well-validated antigens, TCEs may combine the potency of cellular immunotherapy with the precision of biologics — ushering in a new class of therapies for patients unresponsive to conventional immunosuppressants.
      </p>
    </section>

    <div class="cta" aria-label="Contact Prolium">
      <a class="cta-link" href="contact.html">Contact Prolium</a>
    </div>
  </main>

  <script>
    const toggle=document.querySelector('.nav-toggle');
    const drawer=document.getElementById('drawer');
    toggle?.addEventListener('click', ()=>{
      const open = !drawer.classList.contains('open');
      drawer.classList.toggle('open', open);
      toggle.setAttribute('aria-expanded', String(open));
    });

    // Fixed nav shadow on scroll
    const nav = document.querySelector('.nav');
    const setShadow = () => {
      if (window.scrollY > 4) nav.classList.add('scrolled');
      else nav.classList.remove('scrolled');
    };
    setShadow();
    window.addEventListener('scroll', setShadow, { passive: true });
  </script>
</body>
</html>
